These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 1968076
1. "CD3low" human thymocyte populations can readily be triggered via the CD2 and/or CD28 activation pathways whereas the CD3 pathway remains nonfunctional. Pierres A, Cerdan C, Lopez M, Mawas C, Olive D. J Immunol; 1990 Feb 15; 144(4):1202-7. PubMed ID: 1968076 [Abstract] [Full Text] [Related]
2. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes. Turka LA, Ledbetter JA, Lee K, June CH, Thompson CB. J Immunol; 1990 Mar 01; 144(5):1646-53. PubMed ID: 2155264 [Abstract] [Full Text] [Related]
3. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes. Damle NK, Doyle LV. J Immunol; 1989 Sep 15; 143(6):1761-7. PubMed ID: 2570801 [Abstract] [Full Text] [Related]
4. Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules. Massaia M, Perrin L, Bianchi A, Ruedi J, Attisano C, Altieri D, Rijkers GT, Thompson LF. J Immunol; 1990 Sep 15; 145(6):1664-74. PubMed ID: 1975259 [Abstract] [Full Text] [Related]
5. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. Dang NH, Torimoto Y, Shimamura K, Tanaka T, Daley JF, Schlossman SF, Morimoto C. J Immunol; 1991 Nov 01; 147(9):2825-32. PubMed ID: 1717577 [Abstract] [Full Text] [Related]
6. IL-1 alpha is produced by T lymphocytes activated via the CD2 plus CD28 pathways. Cerdan C, Martin Y, Brailly H, Courcoul M, Flavetta S, Costello R, Mawas C, Birg F, Olive D. J Immunol; 1991 Jan 15; 146(2):560-4. PubMed ID: 1670946 [Abstract] [Full Text] [Related]
7. The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells. Costello R, Cerdan C, Pavon C, Brailly H, Hurpin C, Mawas C, Olive D. Eur J Immunol; 1993 Mar 15; 23(3):608-13. PubMed ID: 8095456 [Abstract] [Full Text] [Related]
8. Identification of the anti-CD3-unresponsive subpopulation of CD4+, CD45RA+ peripheral T lymphocytes. Koulova L, Yang SY, Dupont B. J Immunol; 1990 Oct 01; 145(7):2035-43. PubMed ID: 1697875 [Abstract] [Full Text] [Related]
9. Human T cell responses to IL-1 and IL-6 are dependent on signals mediated through CD2. Endler-Jobst B, Schraven B, Hutmacher B, Meuer SC. J Immunol; 1991 Mar 15; 146(6):1736-42. PubMed ID: 1706379 [Abstract] [Full Text] [Related]
10. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. Dang NH, Torimoto Y, Deusch K, Schlossman SF, Morimoto C. J Immunol; 1990 Jun 01; 144(11):4092-100. PubMed ID: 1971293 [Abstract] [Full Text] [Related]
11. Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. Cerdan C, Martin Y, Courcoul M, Brailly H, Mawas C, Birg F, Olive D. J Immunol; 1992 Oct 01; 149(7):2255-61. PubMed ID: 1356123 [Abstract] [Full Text] [Related]
12. Regulation of T-cell differentiation by CD2 and CD28 accessory molecules. de Jong R, Stokkers P, Lamme E, Kool JM, Borst F, Brouwer M, Miedema F, van Lier RA. Immunology; 1991 Oct 01; 74(2):175-82. PubMed ID: 1684171 [Abstract] [Full Text] [Related]
13. Role of CD2 cross-linking in cytoplasmic calcium responses and T cell activation. Ledbetter JA, Rabinovitch PS, Hellström I, Hellström KE, Grosmaire LS, June CH. Eur J Immunol; 1988 Oct 01; 18(10):1601-8. PubMed ID: 2461308 [Abstract] [Full Text] [Related]
14. CD2 can mediate TCR/CD3-independent T cell activation. Ohno H, Ushiyama C, Taniguchi M, Germain RN, Saito T. J Immunol; 1991 Jun 01; 146(11):3742-6. PubMed ID: 1674520 [Abstract] [Full Text] [Related]
15. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. Dang NH, Torimoto Y, Sugita K, Daley JF, Schow P, Prado C, Schlossman SF, Morimoto C. J Immunol; 1990 Dec 15; 145(12):3963-71. PubMed ID: 1979581 [Abstract] [Full Text] [Related]
16. Differential regulation of Ca2+ mobilization in human thymocytes by coaggregation of surface molecules. Deusch K, Daley JF, Levine H, Languet AJ, Anderson P, Schlossman SF, Blue ML. J Immunol; 1990 Apr 15; 144(8):2851-8. PubMed ID: 1691220 [Abstract] [Full Text] [Related]
17. Triggering CD 28 molecules synergize with CD 2 (T 11.1 and T 11.2)-mediated T cell activation. Pierrès A, Lopez M, Cerdan C, Nunes J, Olive D, Mawas C. Eur J Immunol; 1988 May 15; 18(5):685-90. PubMed ID: 2454190 [Abstract] [Full Text] [Related]
18. Activation of the interleukin 2 pathway precedes CD3-T cell receptor expression in thymic development. Differential growth requirements of early and mature intrathymic subpopulations. Toribio ML, De la Hera A, Marcos MA, Márquez C, Martínez C. Eur J Immunol; 1989 Jan 15; 19(1):9-15. PubMed ID: 2522051 [Abstract] [Full Text] [Related]
19. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy. Verwilghen J, Vandenberghe P, Wallays G, de Boer M, Anthony N, Panayi GS, Ceuppens JL. J Immunol; 1993 Feb 01; 150(3):835-46. PubMed ID: 7678624 [Abstract] [Full Text] [Related]